How to manage the complexities of synthetic API production in 30 steps
The manufacturing pathway for a specialist synthetic active pharmaceutical ingredient (API) holds considerable complexities when scaling up from discovery. We learn how CDMO Indena set about developing a bespoke solution that had never been attempted before on such a scale, involving 30 steps.
